Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
arcticnovartis
- Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in US
- Site to serve patients in Southern US and add network capacity as RLT expands into earlier treatment lines and additional tumor types
- Company broke ground on 4 new manufacturing and R&D facilities, initiated 3 facility expansions, and announced 2 additional sites in last 10 months, rapidly making progress on its commitment to expand its US operations